Mark S. Blumenkranz - 15 Jul 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role: Director
Signature: /s/ Todd D.C. Anderman, as Attorney-in-Fact for Mark S. Blumenkranz
Issuer symbol: N/A
Transactions as of: 15 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 19 Jul 2022, 16:09:29 UTC
Previous filing: 17 Jun 2022
Next filing: 02 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise	$0	+5,000	+40%	$0.000000	17,500	15 Jul 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Restricted Stock Units	Options Exercise	$0	-5,000	-50%	$0.000000	5,000	15 Jul 2022	Common Stock	5,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2	On July 15, 2020, the Reporting Person was granted 15,000 restricted stock units, which vest annually with respect to 1/3rd of the shares underlying such award until the third anniversary of the grant date, subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.